REGULATORY
Welfare Recipients Should Pay Difference between Generic and Branded Drug Prices: MOF
The Ministry of Finance (MOF) on October 27 called for requiring people on welfare to pay the difference between generic prices and original drug prices if they opt for branded medicines with generic substitutes available. The MOF made the pitch…
To read the full story
Related Article
- Long-Listed Drug Use by Welfare Recipients Should Require Copay: MOF
October 28, 2016
REGULATORY
- Pharma Urges Pricing Rewards to Bolster Japan’s Drug Discovery Strength
September 24, 2026
- New Digital Minister Furukawa Pledges Push for Healthy Longevity
September 24, 2026
- MHLW Eyes Higher Long-Term Care Premiums for Wealthier Seniors
September 24, 2026
- Nippon Ishin’s Urano Named Senior Vice Health Minister in Takaichi Cabinet
September 24, 2026
- Ueno Vows to Advance Drug Innovation, Advanced Medicine in 2nd Term
September 24, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





